fda semaglutide news 🎉Exciting that is now approved for MASH (aka fatty liver disease) “At week 72, the primary efficacy endpoint was based on histology (liver biopsy results). Interim results showed 63% Americans turn to risky unregulated

Common side effects are much more likely to include mild nausea, constipation, or indigestion, which are generally manageable and tend to improve over time as your body adjusts

Stopping an effective weight loss and metabolic health medication for a symptom that responds to dietary changes and OTC medications would mean losing significant health benefits

However, it is produced in a facility that may process these allergens

Our answer is rarely stop. Its usually some version of: Stay on the therapeutic dose for at least 3 to 6 months past goal weight to consolidate the loss Step down carefully (if appropriate), watch the scale, and make adjustments as needed Extend the interval for patients maintaining well on any dose, high or low

GLP-1 medications like Ozempic, Wegovy, and Mounjaro have become almost impossible to escape

W.CirilliM.LinC.XuH